title: Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter setting.
abstract: Flow-cytometric detection of minimal residual disease (MRD) has proven in several single-institute studies to have an independent prognostic impact. We studied whether this relatively complex approach could be performed in a multicenter clinical setting. Five centers developed common protocols to accurately define leukemia-associated (immuno)phenotypes (LAPs) at diagnosis required to establish MRD during/after treatment. List mode data files were exchanged, and LAPs were designed by each center. One center, with extensive MRD experience, served as the reference center and coordinator. In quarterly meetings, consensus LAPs were defined, with the performance of centers compared with these. In a learning (29 patients) and a test phase (35 patients), a mean of 2.2 aberrancies/patient was detected, and only 1/63 patients (1.6%) had no consensus LAP(s). For the four centers without (extensive) MRD experience, clear improvement could be shown: in the learning phase, 39-63% of all consensus LAPs were missed, resulting in a median 30% of patients (range 21-33%) for whom no consensus LAP was reported; in the test phase, 27-40% missed consensus LAPs, resulting in a median 16% (range 7-18%) of 'missed' patients. The quality of LAPs was extensively described. Immunophenotypic MRD assessment in its current setting needs extensive experience and should be limited to experienced centers.
authors.affiliation: Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
authors.forename: N
authors.initials: N
authors.lastname: Feller
authors.forename: V H J
authors.initials: VH
authors.lastname: van der Velden
authors.forename: R A
authors.initials: RA
authors.lastname: Brooimans
authors.forename: N
authors.initials: N
authors.lastname: Boeckx
authors.forename: F
authors.initials: F
authors.lastname: Preijers
authors.forename: A
authors.initials: A
authors.lastname: Kelder
authors.forename: I
authors.initials: I
authors.lastname: de Greef
authors.forename: G
authors.initials: G
authors.lastname: Westra
authors.forename: J G
authors.initials: JG
authors.lastname: Te Marvelde
authors.forename: P
authors.initials: P
authors.lastname: Aerts
authors.forename: H
authors.initials: H
authors.lastname: Wind
authors.forename: M
authors.initials: M
authors.lastname: Leenders
authors.forename: J W
authors.initials: JW
authors.lastname: Gratama
authors.forename: G J
authors.initials: GJ
authors.lastname: Schuurhuis
references.citation: Am J Clin Pathol. 2009 Jan;131(1):16-26
references.pmid: 19095561
references.citation: Leuk Lymphoma. 2007 Jan;48(1):80-8
references.pmid: 17325851
references.citation: Blood. 2003 May 1;101(9):3398-406
references.pmid: 12506020
references.citation: Cytometry B Clin Cytom. 2007 May;72(3):178-88
references.pmid: 17397065
references.citation: Blood. 2012 Jan 12;119(2):332-41
references.pmid: 22039260
references.citation: Leukemia. 2004 Aug;18(8):1380-90
references.pmid: 15201848
references.citation: Lancet Oncol. 2010 Jun;11(6):543-52
references.pmid: 20451454
references.citation: J Clin Oncol. 2006 Aug 1;24(22):3686-92
references.pmid: 16877738
references.citation: Leukemia. 2003 Jan;17(1):68-75
references.pmid: 12529662
references.citation: Blood. 1997 Sep 15;90(6):2465-70
references.pmid: 9310499
references.citation: Blood. 2000 Dec 1;96(12):3948-52
references.pmid: 11090082
references.citation: J Biol Regul Homeost Agents. 2004 Jul-Dec;18(3-4):313-26
references.pmid: 15786698
references.citation: Cytometry. 1999 Aug 15;38(4):139-52
references.pmid: 10440852
references.citation: Blood. 2001 Jun 1;97(11):3574-80
references.pmid: 11369653
references.citation: Leukemia. 2010 Sep;24(9):1599-606
references.pmid: 20668473
references.citation: Blood. 2004 Nov 15;104(10):3078-85
references.pmid: 15284114
references.citation: Haematologica. 2009 Aug;94(8):1135-50
references.pmid: 19586938
references.citation: J Clin Pathol. 1996 Jan;49(1):15-8
references.pmid: 8666678
references.citation: Blood. 2001 Sep 15;98(6):1746-51
references.pmid: 11535507